Devlife Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.45 Cr
- Revenue Growth %
- Profit Growth -6.29%
- Ebitda -10.86%
- Net Worth -249.73%
- Total Assets 198.77%
About Devlife Therapeutics
Devlife Therapeutics Private Limited (DTPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 May 2020 (Four years and eight months 19 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹11.45 Cr.
Roopa Ramesh and Vaishali Anjaria serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36999MH2020PTC340044
-
Company No.
340044
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 May 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Devlife Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roopa Ramesh
|
Director | 27-May-2020 | Current |
|
Vaishali Anjaria
|
Director | 27-May-2020 | Current |
Financial Performance of Devlife Therapeutics.
Devlife Therapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 6.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 249.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devlife Therapeutics?
In 2022, Devlife Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Devlife Corporation Private LimitedRoopa Ramesh and Vaishali Anjaria are mutual person
-
Sarvam Pharmatech Private LimitedVaishali Anjaria is a mutual person
Charges (Loans)
₹11.45 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 11.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Oct 2023 | Hdfc Bank Limited | ₹11.45 Cr | Open |
How Many Employees Work at Devlife Therapeutics?
Devlife Therapeutics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devlife Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devlife Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.